Some North Carolinians may be eligible for compensation if they paid too much for generic prescription drugs made by Heritage ...

What Is ADHD (Attention Deficit Hyperactivity Disorder)? Attention deficit hyperactivity disorder (ADHD) is a commonly diagnosed neurological condition. It affects more than 8% of children and 2.5% of ...

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem ...

Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Diltiazem Hydrochloride ...

David Coghill; Tobias Banaschewski; Alessandro Zuddas; Antonio Pelaz; Antonella Gagliano; Manfred Doepfner ...

The company’s commercial portfolio comprises its marketed pain-management drugs, Belbuca, Xtampza ER, Nucynta IR and ... strategic move added Jornay PM (methylphenidate HCl), a central nervous ...

Amphetamine- and methylphenidate-based drugs are the first-choice medications used for treating many people with attention deficit hyperactivity disorder (ADHD). They are available in a generic ...

Bonus Dec 05, 2019 Dec 07, 2019 Oct 23, 2019 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Mar 19, 2015 Mar 20, 2015 Jan 30, 2015 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Mar 15, ...